Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 116 | 88 | −28 |
| Shares | 60.4M | 55.5M | −4.90M (−8.1%) |
| Value | $172.2M | $183.2M | +$11.0M (+6.4%) |
New holders (15)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 596,695 | $1.97M | 0.02% |
| RBF Capital, LLC | 154,100 | $508.5K | 0.03% |
| Opaleye Management Inc. | 143,600 | $473.9K | 0.11% |
| Acuitas Investments, LLC | 134,815 | $444.9K | 0.26% |
| Bridgeway Capital Management, LLC | 126,500 | $417.4K | 0.01% |
| MYDA Advisors LLC | 50,000 | $165.0K | 0.06% |
| Ergoteles LLC | 40,800 | $134.6K | 0.01% |
| Laurion Capital Management LP | 33,645 | $111.0K | 0.00% |
| Mirabella Financial Services LLP | 32,760 | $108.1K | 0.01% |
| Franklin Resources Inc | 28,356 | $93.6K | 0.00% |
| Marquette Asset Management, LLC | 27,867 | $92.0K | 0.02% |
| Old Mission Capital LLC | 23,900 | $78.9K | 0.00% |
| Prelude Capital Management, LLC | 11,171 | $36.9K | 0.00% |
| Balyasny Asset Management LLC | 11,087 | $36.6K | 0.00% |
| DRW Securities, LLC | 11,000 | $36.0K | 0.00% |
Sold out (43)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.